Open AccessVenetoclax-Obinutuzumab Therapy
Author(s) -
Mark L. Fuerst
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000735188.92076.5b
Subject(s) - obinutuzumab , venetoclax , chlorambucil , oncology , medicine , fludarabine , regimen , chronic lymphocytic leukemia , minimal residual disease , leukemia , chemotherapy , cyclophosphamide